SIRPA and neoplasm: First, macrophages and related myeloid cells with both SIRPα blockade and FcR-engaging, tumor-targeting IgG maximize survival of mice with WT B16+Rev tumors (Figure 3E) – noting that macrophages express SIRPα and FcRs, but most or all T cells do not.